Implementation of an interactive, risk adaptive cardio oncological survivorship platform using continuous cardiovascular monitoring

Clicks: 1
ID: 323447
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #239 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Long-term cancer survivors are at increased risk for cardiovascular complications related to cardiotoxic therapies, thoracic surgery, and metabolic sequelae. In current clinical practice, cardio-oncological follow-up relies largely on fixed-interval visits and imaging, providing only episodic assessments of cardiovascular health. Subclinical changes in functional status, heart rate variability, or physical activity may therefore remain undetected between visits, despite their potential relevance for early cardiovascular risk stratification and individualized survivorship care. Purpose KI-COMPASS is a project funded by the German Federal Ministry of Research, Technology and Space (BMFTR) under the directive "Interactive Technology for cardio-oncological Aftercare". The project aims to develop and clinically evaluate an interactive, risk-adaptive follow-up platform integrating continuous cardiovascular monitoring with routine cardiological assessments in survivors of gastro-oesophageal adenocarcinoma. A central objective is the development of transparent, model-based digital patient representations to support personalized risk assessment and longitudinal simulation of cardiovascular trajectories. Methods In a prospective exploratory setting, 100 patients in oncological survivorship care will be enrolled. Continuous physiological and functional parameters, including heart rate, heart rate variability, activity, and sleep patterns, will be collected via wearable devices and smartphones and combined with standard cardiological data such as echocardiography, biomarkers, and documented cardiovascular events. The multimodal data streams will be integrated into patient-specific digital models, enabling longitudinal risk profiling and scenario-based simulation. Results will be presented in a clinician-facing dashboard designed as decision support, preserving cardiologist-led interpretation and clinical responsibility. Risk-adaptive follow-up strategies will be evaluated in simulated clinical scenarios. Expected Results The project is expected to demonstrate the feasibility and clinical acceptability of integrating continuous cardiovascular data into routine cardio-oncological follow-up. Anticipated benefits include improved detection of early functional deterioration, enhanced longitudinal risk awareness between scheduled visits, and support for individualized surveillance strategies. Model-based simulations may enable intensified monitoring for high-risk patients while avoiding unnecessary testing in low-risk survivors. Conclusion KI-COMPASS represents a clinically oriented, publicly funded approach toward interactive and personalized cardio-oncological survivorship care. By complementing guideline-based follow-up with continuous cardiovascular monitoring, transparent AI-based modelling, and expert-guided interpretation, the project aims to inform future models of risk-adaptive, patient-centered cardio-oncology care in routine clinical practice.
Reference Key
openalex_W7172281560 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors I Bojti, D Westermann, J Wehrle, A Hornecker, O Amft, A Kumar, M Cypko, M Quante
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2026
DOI
10.1093/eurheartjsupp/suag097.234
URL
https://doi.org/10.1093/eurheartjsupp/suag097.234
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.